Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sera Prognostics (SERA – Research Report), Medpace...

Market Cap	$15.47B	P/E Ratio	38.50
52W High	$628.92	52W Low	$250.05
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	37.2%	52W Position	84.4%
Overall Score	63	Value Score	60
Quality Score	76	Technical Score	54

EPS Current Est	$14.8	EPS Next Est	$16.62
EPS Growth Est	+12.3%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$569.74	-3.13%	183.41K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MEDP	$569.74	-3.1%	183.41K
3
4
5
6

MEDP

MEDP

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Medpace Holdings Inc. Data in Excel

Get Medpace Holdings Inc. Data in Excel